Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2025-12-25 @ 3:02 AM
NCT ID: NCT05728333
Eligibility Criteria: Inclusion Criteria: 1. Aged 18 years or older. 2. Presenting with acute ischemic stroke symptom. 3. Time from onset to hospital arrival: * (1) within 4.5 hours * (2) 4.5-9.0 hours, image inclusion criteria for the EXTEND trial must be met * (3) \> 4.5 hours but within 24 hours, image inclusion criteria for the WAKE-UP trial must be met. 4. Eligible for intravenous thrombolysis. 5. Occlusion of the internal carotid artery, M1 or M2 segment of the middle cerebral artery, vertebrobasilar artery confirmed by CTA, MRA, or DSA. 6. Informed consent obtained from patients or their legal representatives. Exclusion Criteria: 1. CT or MR evidence of hemorrhage (the presence of micro-bleeds is allowed); 2. Contraindications of IV rt-PA or tirofiban; 3. Contraindication to radiographic contrast agents, nickel, titanium metals or their alloys; 4. Arterial tortuosity and/or other arterial disease that would prevent the device from reaching the target vessel; 5. Patients with a preexisting neurological or psychiatric disease that would confound the neurological functional evaluations; 6. CT or MRI evidence of mass effect or intracranial tumor (except small eningioma); 7. CT or MRI evidence of cerebral vasculitis; 8. CTA or MRA evidence of intracranial arteriovenous malformations or aneurysms; 9. Any terminal illness with life expectancy less than 6 months.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT05728333
Study Brief:
Protocol Section: NCT05728333